Insider · CIK 0001652067
Matthew Winkler
Files at AKYA (Akoya Biosciences, Inc.). First filing -, latest -.
Matthew Winkler files SEC Form 4 as director at AKYA (Akoya Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Matthew Winkler has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Common Stock | -984,513 | - | - | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | -16,860 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -30,549 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -56,322 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -50,000 | $0.00 | $0 | 0 | Jul 10, 2025 |
Questions about Matthew Winkler
Answered from the filings on this page, as of the latest one.
Is Matthew Winkler buying or selling?
Matthew Winkler has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Matthew Winkler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew Winkler has 0.
Where does Matthew Winkler file Form 4?
Matthew Winkler has filed Form 4 at AKYA (Akoya Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.